Precision Business Insights
Portfolio

 

Research Reports

Global Neuroblastoma Treatment Market: Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Neuroblastoma Treatment Market: By Diagnostics (MIBG Scan, Imaging, Urine Analysis, and Biopsy), By Drugs (Crizotinib, Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine Sulfate, and Others), By Treatment (Surgery, Chemotherapy, High-Dose Chemotherapy with Stem Cell Support, Monoclonal Antibody Treatment, Radiotherapy, and Others), and Geography

 

Global Neuroblastoma Treatment Market

 

Global Neuroblastoma Treatment Market Report Description:

Global neuroblastoma treatment market report gives comprehensive outlook on neuroblastoma treatment across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global neuroblastoma treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of diagnostics, drugs, treatment, and region. This report studies global neuroblastoma treatment market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neuroblastoma treatment market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global neuroblastoma treatment market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global neuroblastoma treatment market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global neuroblastoma treatment products.

 

Global Neuroblastoma Treatment Market:

The global neuroblastoma treatment market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 owing to increasing prevalence of cancer across the globe coupled with rising healthcare expenses and more number of awareness programs on neuroblastoma coupled with government initiatives to support the patients drives the growth of the neuroblastoma treatment market. For instance, According to America Cancer Society, neuroblastoma accounts for over 7% of the total cancer cases in age group of 0 to 14 years of age. Moreover, support by the government and favorable healthcare reimbursement policies drives the growth of the market over the forecasted period. However, high cost of treatment for neuroblastoma disorders are expected to restrain the growth of the market over the future years.

 

North America Accounts for Larger Market Revenue Share in Global Neuroblastoma Treatment Market

North America accounted for larger revenue share in global neuroblastoma treatment market with significant CAGR and is expected to grow over the forecast years owing to increasing number of product approvals and presence of large number of market players in the region and favorable reimbursement polices drives the growth of the market over the forecast period. Europe is expected to show faster growth rate due to favorable government initiatives for improving respiratory care, such as European Committee for Hyperbaric Medicine (ECHM), involved in promoting awareness pertaining to the treatment. Asia Pacific is expected to grow at a significant growth rate owing to increasing prevalence of neuroblastoma in the region.

 

Competition Assessment

Key player’s profiles in the global neuroblastoma treatment market include:

  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Pfizer
  • Teva Pharmaceutical
  • United Therapeutics
  • Amneal Pharmaceuticals, Inc.

 

Key Findings of the Report:

 

  • Global neuroblastoma treatment market expanding at significant CAGR over 2018 to 2024 owing to increasing prevalence of cancer across the globe.
  • Based on region, North America accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global neuroblastoma treatment market

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Diagnostics  

  • MIBG Scan
  • Imaging
  • Urine Analysis
  • Biopsy

By Drugs

  • Crizotinib
  • Doxorubicin Hydrochloride
  • Cyclophosphamide
  • Vincristine Sulfate
  • Others

By Treatment

  • Surgery
  • Chemotherapy
  • High-Dose Chemotherapy with Stem Cell Support
  • Monoclonal Antibody Treatment
  • Radiotherapy
  • Others

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

  1. Executive Summary
  2. Global Neurological Disorder Diagnostics Market Introduction
    • Global Neurological Disorder Diagnostics Market – Taxonomy
    • Global Neurological Disorder Diagnostics Market –Definitions
      • By Technology
      • By Indication
      • By End User
      • By Region
  1. Global Neurological Disorder Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Neurological Disorder Diagnostics Market Dynamics – Factors Impact Analysis
  2. Global Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Neurological Disorder Diagnostics Market Forecast, By Technology, 2014 – 2018 and Forecast, 2019 – 2025
    • Imaging
      • Computed Tomography (CT)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetic Resonance Imaging (MRI)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Electroencephalography (EEG)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Single-Photon Emission Computed Tomography (SPECT)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Nuclear Medicine Imaging
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetoencephalography (MEG)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Positron Emission Tomography (PET)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Ultrasound Imaging
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • In-Vitro Diagnostics
        • Biomarker
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Biopsy
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Indication, 2014 – 2018 and Forecast, 2019 – 2025
    • Genetic Neurological Disorders
      • Alzheimer’s Disease (AD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Parkinson’s Disease (PD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Huntington’s Disease (HD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Amyotrophic Lateral Sclerosis (ALS)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Immunological Neurological Disorders
        • Multiple Sclerosis
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraneoplastic Syndrome 
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraproteinemic Neuropathies 
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospitals & Clinics 
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers 
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Care Centers 
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Region, 2019 – 2025
  2. North America Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US.
        • Canada
      • North America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • North America Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Europe Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers  
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • UK.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
      • Europe Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Europe Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Asia Pacific Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers  
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • China
        • Japan
        • India
        • ASEAN Counties
        • Philippines
        • Rest of Asia Pacific
      • Asia Pacific Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Asia Pacific Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Latin America Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers  
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Mexico
        • Brazil
        • Argentina
        • Chile
        • Rest of Latin America
      • Latin America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Latin America Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers  
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • GCC Countries
        • South Africa
        • Saudi Arabia
        • Turkey
        • Rest of MEA
      • Middle East and Africa Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Middle East and Africa Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Siemens Healthineers
      • Koninklijke Philips N.V.
      • General Electric Company
      • Esaote SpA
      • NeuroLogica Corporation
      • Masimo Corporation
      • York Instruments Ltd.
      • Neusoft Medical Systems
      • Canon Medical Systems Corporation
      • Smith & Nephew Inc
      • Johnson & Johnson
  1. Research End Userology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials